Skip to content
value.today

EPALEX Corp

Total raised
$30 M
4 rounds on record
Latest round
$1 M
Oct 2025
First round on record
Dec 2018
Today
Private
No later event on record

Funding rounds

4 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of EPALEX Corp
MonthRaisedRaiseSizeInvestorsSoldFiling
Oct 2025$1 MNo. 4Under $2 million

EPALEX Corp: Raise no. 4, Oct 2025

Investors in this round

1 investor had bought by the notice of Nov 10, 2025: 1 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$1 M of $3 M offered; $2 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Brendan Magrab · Executive Officer, Director
  • Didric Cedarholm · Director
  • Jon Saxe · Director
  • Michael Rogawski · Director
  • Randall Murphy · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the use of proceeds: “The proceeds are available to fund general working capital requirements; as of the date of this filing, no detailed operating budget has been adopted; and no proceeds have been or are proposed to be used for payments of finders fees or other compensation.”

Signed by Brendan Magrab, Chief Executive Officer. Source: SEC Form D, newest notice filed Nov 10, 2025. Read the notice at the SEC.

equitySEC
Dec 2024$4 MNo. 3$2 to $10 million

EPALEX Corp: Raise no. 3, Dec 2024

Investors in this round

1 investor had bought by the notice of Dec 20, 2024: 1 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$4 M of $15 M offered; $11 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Brendan Magrab · Executive Officer, Director
  • Didric Cederholm · Director
  • Jon S. Saxe · Director
  • Michael Rogawski · Director
  • Randall Murphy · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the use of proceeds: “The proceeds are available to fund general working capital requirements; as of the date of this filing, no detailed operating budget has been adopted; and no proceeds have been or are proposed to be used for payments of finders fees or other compensation.”

Signed by Brendan Magrab, Chief Executive Officer. Source: SEC Form D, newest notice filed Dec 20, 2024. Read the notice at the SEC.

equitySEC
Oct 2022$4 MNo. 2$2 to $10 million

EPALEX Corp: Raise no. 2, Oct 2022

Investors in this round

15 investors had bought by the notice of Oct 14, 2022: 15 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$4 M of $9 M offered; $4 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
$650,000 (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Brendan Magrab · Executive Officer, Director
  • Jon S. Saxe · Director
  • Matthew S. Smith · Director
  • Michael Rogawski · Director
  • Randall Murphy · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the use of proceeds: “Estimated total cash compensation in respect of fiscal year ending December 31, 2022.”

Signed by Brendan Magrab, President and Chief Executive Officer. Source: SEC Form D, newest notice filed Oct 14, 2022. Read the notice at the SEC.

equitySEC
Dec 2018$20 MNo. 1$10 to $50 million

EPALEX Corp: Raise no. 1, Dec 2018

Investors in this round

7 investors had bought by the notice of Dec 18, 2020: 7 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$20 M of $20 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Brendan Magrab · Executive Officer, Director
  • Jon S. Saxe · Director
  • Matthew S. Smith · Director
  • Michael S. Rogawski · Director
  • Randall S. Murphy · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Brendan Magrab, President and Chief Executive Officer. Source: SEC Form D and 1 amendment, newest notice filed Dec 18, 2020. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • EPALEX Corp chose not to state its revenue in its newest notice of a funding round (Nov 2025).

    SEC Form D · Nov 2025

  • The industry group it chose in its notices: Pharmaceuticals.

    SEC Form D · Nov 2025

That is all the official record says: EPALEX Corp has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of EPALEX Corp is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 4 rounds above had up to 15 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by EPALEX Corp
NameRoleNamed in
Brendan MagrabExecutive officerNov 2025
Arthur Franklin RiceExecutive officerJan 2019
Steven F LincolnExecutive officerJan 2019
Brendan MagrabDirectorNov 2025
Didric CedarholmDirectorNov 2025
Jon SaxeDirectorNov 2025
Michael RogawskiDirectorNov 2025
Randall MurphyDirectorNov 2025
Didric CederholmDirectorDec 2024
Jon S. SaxeDirectorDec 2024
Matthew S. SmithDirectorOct 2022
Michael S. RogawskiDirectorDec 2020
Randall S. MurphyDirectorDec 2020
Arthur Franklin RiceDirectorJan 2019
Jon S SaxeDirectorJan 2019
Matthew B SmithDirectorJan 2019
Michael A RogawskiDirectorJan 2019
Randall B MurphyDirectorJan 2019